Blauvelt A, Eichenfeld L, Kuligowski M, Venturanza M, Sun K, Silverberg J. Long-term safety and disease control with ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2024 Jul. 3];5(6):s65. Available from: https://jofskin.org/33014/index.php/skin/article/view/1416